Anneke J. van Vuuren

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy

Lieke Hol, Monique E. van Leerdam, Marjolein van Ballegooijen et al. · Gut · 2009 · 483 citations

Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

Erik H.C.J. Buster, Hajo J. Flink, Yılmaz Çakaloğlu et al. · Gastroenterology · 2008 · 394 citations · Full text

Autoimmune Disease, Hbsag Loss, Peginterferon α-2B +4

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels

Lieke Hol, Janneke Wilschut, Marjolein van Ballegooijen et al. · British Journal of Cancer · 2009 · 273 citations · Full text

Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels†

Vincent Rijckborst, Bettina E. Hansen, Yılmaz Çakaloğlu et al. · Hepatology · 2010 · 237 citations · Full text

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels

Esther Toes‐Zoutendijk, Monique E. van Leerdam, Evelien Dekker et al. · Gastroenterology · 2016 · 216 citations · Full text

First Year, Real-time Monitoring, Oncology +13